Absolute Bioavailability of Reslizumab in Healthy Subjects
Clinical trial NCT01990443 · COMPLETED
Trial details
- NCT number
- NCT01990443
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2013-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.